supported by Grants from the Key Program of the National Natural Science Foundation of China(81230013);the Major State Basic Research Development Program of China(973 Program,2013CB733701);the Nature Science Foundation of China(81170483,81570130 and 81370639);the Beijing Municipal Science and Technology Commission(Z141100000214011);support from the NIHR Biomedical Research Centre funding scheme
Background:Acute myeloid leukemia(AML) with t(8;21) is a heterogeneous disease.Identifying AML patients with t(8;21) who have a poor prognosis despite achieving remission is important for determining the best subseque...
The Szent-Gyorgyi Prize for Progress in Cancer Research is a prestigious scientific award established by the National Foundation for Cancer Research(NFCR)—a leading cancer research charitable organization in the Unit...
The Szent-Gyrgyi Prize for Progress in Cancer Research is a prestigious scientific award established by the National Foundation for Cancer Research(NFCR)—a leading cancer research charitable organization in the Unite...
To facilitate and strengthen collaborations among cancer researchers and physicians in the United States and China,the US Chinese AntiCancer Association(USCACA)and the National Foundation for Cancer Research(NFCR)have...
Chinese researchers and physicians are being increasingly recognized for making significant contributions that advance biomedical research,including cancer research,in both China and the world.